Shutterstock |
Memo to Sen. Rand Paul and everyone else who needs to hear it: Not everything in the world revolves around Donald J. Trump. Just stop, for the love of God. -
Federal researchers will not objectively study ivermectin as a treatment for Covid-19, the Kentucky senator Rand Paul claimed, because “hatred for Donald Trump” has tainted their view of those who say the drug used to deworm horses can aid the fight against the pandemic.
Ivermectin, an anti-parasitic, does have uses in humans, to treat worms, lice and skin problems. But despite it having been discussed by doctors in testimony before Congress, it is not proven to combat Covid-19.
Doctors have also warned against its potential toxicity. Earlier this month, the US Food and Drug Administration (FDA) issued a terse tweet: “You are not a horse. You are not a cow. Seriously, y’all. Stop it.”
The Cincinnati Enquirer reported that a meeting with constituents in Cold Spring, Kentucky, on Friday, Paul said: “The hatred for Trump deranged these people so much, they’re unwilling to objectively study it.
“So someone like me that’s in the middle on it, I can’t tell you because they will not study ivermectin. They will not study hydroxychloroquine without the taint of their hatred for Donald Trump.”
Trump both promoted and said he was using hydroxychloroquine, an anti-malarial drug, when in office. Doctors warned against side-effects and studies said it had little or no effect in preventing hospitalisation or death from Covid-19.
According to the US National Library of Medicine, studies have not produced proof that ivermectin can treat Covid-19. The same source lists 31 completed, withdrawn or ongoing US clinical trials.
The FDA says taking large doses of ivermectin is “dangerous and can cause serious harm” and adds: “Never use medications intended for animals on yourself. Ivermectin preparations for animals are very different from those approved for humans.” (Read more)
Copyright 2021, Sunking278. Stay up-to-date: Twitter – @Sunking278 and Facebook – click here.
No comments:
Post a Comment